SMAD3 and skin basal cell carcinoma: Due to JunD, but not Smad3 sufficiency in driving the AP-1/Smad/Rho/MRTF resistance pathway, we hypothesized that JunD/AP-1 regulates the unique chromatin accessibility profile that functions with TGFß signaling in resistant nMRTF BCC.